64,95 €
64,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
32 °P sammeln
64,95 €
64,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
32 °P sammeln
Als Download kaufen
64,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
32 °P sammeln
Jetzt verschenken
64,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
32 °P sammeln
  • Format: ePub

Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. Provides efficacy research on ketamine as a treatment for depression | Identifies best practices for clinical use, both long-term and acute | Discusses the molecular mechanisms and neurobiology of action

Produktbeschreibung
Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics.
  • Provides efficacy research on ketamine as a treatment for depression
  • Identifies best practices for clinical use, both long-term and acute
  • Discusses the molecular mechanisms and neurobiology of action

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Gustavo H. Vazquez is a Full Professor at the School of Medicine, Queen's University, Director of the CME and staff member of the Mood Disorders Research and Treatment Service, Department of Psychiatry, Providence Care Hospital, Kingston, ON, Canada. He is a member of the Centre for Neuroscience Studies (CNS) at Queen's University (Kingston, Canada), member of the Centre of Neurosicence at Palermo University (Buenos Aires, Argentina) and member of the International Consortium for Psychotic and Bipolar Disorders Research at McLean Hospital, Harvard Medical School (Boston, United States of America).
Rezensionen
"This is the first book that specifically focuses on ketamine for treatment-resistant depression. This topic has been covered in lectures, articles, and briefly in some textbooks, but this is the first book I have read that specifically covers it. Given the limited available data, the book succeeds in its stated goal to inform readers about what is currently known about ketamine. Updated editions will be needed to reflect the growing knowledge base and eventual treatment strategies using ketamine." --© Doody's Review Service, 2020, Aaron Plattner, MD(Pine Rest Christian Mental Health Services), reviewer, expert opinion